Efficacy of Lauq Nazali in Allergic Rhinitis â?? An Open Labelled Interventional Clinical Trial.

ational Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Symptoms persisted for more than 4 days per week or more than 4 weeks per year and at least one of the following rhinitis-associated conditions: nasal congestion, rhinorrhea, sneezing and nasal itching
•2.Patients who will give consent and able to do follow up

•1.Patients suffering from systemic illness like Hypertension, DM, Malignancy, Liver or Kidney dysfunction
•2.Patients suffering from congenital nasal abnormalities like nasal dermoid cysts, congenital midline nasal masses, Deviated Nasal Septum, Atrophic rhinitis, Sinusitis, Hypertrophic turbinates, Adenoidal hypertrophy, Foreign bodies or Asthma
•3.Patients below 18 and above 50 years
•4.Patients with past history of nose surgery
•5.Patients had received systematically administered corticosteroids, antihistamines, decongestants or CAM therapy within 02 weeks prior to enrolment
•6.Pregnant and lactating women

发起方

ational Institute of Unani Medicine